Literature DB >> 8052112

Arterial blood pressure response to rowing.

P S Clifford1, B Hanel, N H Secher.   

Abstract

Ten male oarsmen performed a 6-min bout of "all-out" exercise on a rowing ergometer in the laboratory. Intraarterial blood pressure was recorded from a catheter inserted percutaneously into the radial artery. Mean arterial pressure increased only modestly from 110 +/- 13 to 122 +/- 24 mm Hg (P < 0.05). Large fluctuations in pressure were superimposed on the normal blood pressure waveform during rowing. These rhythmic pressure fluctuations exhibited a one-to-one coupling with stroke rate and were 2-3 times the magnitude of the normal pulse pressure. Thus, the effective pulse pressure during the 1st minute of rowing (112 +/- 11 mm Hg) was markedly higher (P < 0.01) than the pulse pressure at rest (45 +/- 5 mm Hg) and remained so throughout the exercise bout. In five additional subjects in which central venous pressure (CVP) was measured, large stroke-related fluctuations in pressure were also seen in the CVP waveform. Similar fluctuations in blood pressure were observed during repetitive Valsalva maneuvers. These results suggest that the blood pressure response to rowing is principally influenced by a Valsalva-like maneuver performed at the catch of each stroke. The observed arterial pressure fluctuations may explain the degree of myocardial hypertrophy that occurs in the hearts of rowers.

Entities:  

Mesh:

Year:  1994        PMID: 8052112     DOI: 10.1249/00005768-199406000-00010

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  9 in total

1.  An echocardiographic assessment of cardiac morphology and common ECG findings in teenage professional soccer players: reference ranges for use in screening.

Authors:  J D Somauroo; J R Pyatt; M Jackson; R A Perry; D R Ramsdale
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

Review 2.  Lymphocyte responses to maximal exercise: a physiological perspective.

Authors:  Henning Bay Nielsen
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

3.  Effect of rowing ergometry and oral volume loading on cardiovascular structure and function during bed rest.

Authors:  Jeffrey L Hastings; Felix Krainski; Peter G Snell; Eric L Pacini; Manish Jain; Paul S Bhella; Shigeki Shibata; Qi Fu; M Dean Palmer; Benjamin D Levine
Journal:  J Appl Physiol (1985)       Date:  2012-02-16

4.  Beta-adrenergic receptor desensitization in man: insight into post-exercise attenuation of cardiac function.

Authors:  Emma Hart; Ellen Dawson; Peter Rasmussen; Keith George; Niels H Secher; Greg Whyte; Rob Shave
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

5.  Cerebral blood flow, frontal lobe oxygenation and intra-arterial blood pressure during sprint exercise in normoxia and severe acute hypoxia in humans.

Authors:  David Curtelin; David Morales-Alamo; Rafael Torres-Peralta; Peter Rasmussen; Marcos Martin-Rincon; Mario Perez-Valera; Christoph Siebenmann; Ismael Pérez-Suárez; Evgenia Cherouveim; A William Sheel; Carsten Lundby; José Al Calbet
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-10       Impact factor: 6.200

Review 6.  Physiological and biomechanical aspects of rowing. Implications for training.

Authors:  N H Secher
Journal:  Sports Med       Date:  1993-01       Impact factor: 11.136

7.  Echocardiographic criteria of physiological left ventricular hypertrophy in combined strength- and endurance-trained athletes.

Authors:  A Urhausen; T Monz; W Kindermann
Journal:  Int J Card Imaging       Date:  1997-02

Review 8.  Impact of Exercise on Cerebrovascular Physiology and Risk of Stroke.

Authors:  Justin A Edward; William K Cornwell
Journal:  Stroke       Date:  2022-05-04       Impact factor: 10.170

Review 9.  Left ventricular hypertrophy in athletes and hypertensive patients.

Authors:  Dragan Lovic; Puneet Narayan; Andreas Pittaras; Charles Faselis; Michael Doumas; Peter Kokkinos
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-03-01       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.